Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess in a prospective multicentric study (Phase III) the
introduction of a monoclonal antibody directed against B-cells associated with a standard
therapy including chemotherapy and alpha-interferon in first line treatment of patients with
a large tumor burden follicular lymphoma.